Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2026-2030

Market Size (2024)

USD 490.08 Million

CAGR (2025-2030)

8.80%

Fastest Growing Segment

Human Breast Milk

Largest Market

North America

Market Size (2030)

USD 812.91 Million

Market Overview

The Global Cell Based Milk Market, valued at USD 490.08 Million in 2024, is projected to experience a CAGR of 8.80% to reach USD 812.91 Million by 2030. Cell-based milk is defined as dairy produced through cellular agriculture methods, utilizing cell cultures from mammals instead of traditional animal farming, offering products chemically identical to conventional milk without requiring animals. This nascent market is primarily driven by escalating consumer demand for sustainable and ethical food alternatives, alongside increasing concerns regarding animal welfare and the environmental impact of conventional dairy production, including reduced land and water usage. According to the Good Food Institute, fermentation companies, encompassing those developing cell-based dairy proteins, secured $515 million in private investments in 2023, reflecting significant capital inflow into this innovative sector.

However, a notable challenge impeding market expansion is the complex landscape of regulatory approval and achieving widespread consumer acceptance for novel food technologies across diverse global regions. Overcoming these hurdles is essential for the cell-based milk market to scale production and achieve broader commercialization.

Key Market Drivers

Continuous advancements in cellular agriculture technology represent a primary driver for the global cell-based milk market, directly addressing the feasibility and scalability of producing milk components without traditional animal farming. Innovations in cell line development, bioreactor efficiency, and media optimization are rendering the process more viable and cost-effective. These technological milestones are crucial for moving cell-based milk from research to commercial production, enhancing product quality, and lowering manufacturing costs. According to the Good Food Institute, in May 2024, New Zealand's Daisy Lab, a precision fermentation biotech company, received approval from the New Zealand Environmental Protection Authority for its application to expand its dairy protein production platform to 5,000 liters, enabling pilot facility construction and significant scaling.

The escalating imperative for environmental sustainability is another significant factor propelling the cell-based milk market. Traditional dairy production contributes to substantial greenhouse gas emissions, extensive land usage, and considerable water consumption. Consumers and industry stakeholders increasingly seek alternatives with a reduced ecological footprint. The pressure to mitigate these environmental impacts is evident throughout the broader dairy sector. According to Emmi’s Annual Report 2024, the 230 dairy farms participating in the KlimaStaR Milk project are expected to achieve a 20% reduction of greenhouse gas emissions by 2027. Cell-based milk benefits from this environmental consciousness, offering a solution with inherently lower resource intensity. This innovative sector continues to attract substantial investment, with total private funding in fermentation technologies, encompassing cell-based dairy proteins, reaching $572 million in 2024, according to the Good Food Institute.


Download Free Sample Report

Key Market Challenges

The complex landscape of regulatory approval and achieving widespread consumer acceptance for novel food technologies across diverse global regions significantly impedes the growth of the Global Cell Based Milk Market. The absence of clear and harmonized regulatory pathways in most jurisdictions directly restricts market entry and commercialization efforts. For example, according to the Good Food Institute, as of December 2023, no country had yet granted commercial regulatory approval for the sale of milk directly produced from animal cell cultures, illustrating the nascent stage of the regulatory framework for this specific novel food technology. This lack of established guidance and approvals prevents companies from effectively scaling production and distribution, directly hindering market expansion.

Furthermore, achieving widespread consumer acceptance for these novel food technologies remains a critical hurdle. Hesitancy regarding products derived from cellular agriculture, often stemming from unfamiliarity or concerns about safety and naturalness, can deter consumer adoption. Without sufficient consumer trust and demand, even products that manage to secure regulatory approval face substantial challenges in achieving commercial viability and market penetration. This dual challenge of navigating complex regulatory environments and building consumer confidence directly limits the potential for significant market development for cell-based milk globally.

Key Market Trends

The global cell-based milk market is significantly influenced by strategic industry partnerships and collaborations, which are accelerating product development and commercialization. These alliances enable startups to leverage established distribution networks and market expertise from food and dairy entities. According to the Good Food Institute Europe, precision fermentation companies, including non-animal dairy protein developers, raised €49 million in the first half of 2024, up from €33 million in 2023, indicating growing investment in collaborative efforts. Partnerships are crucial for scaling production and navigating regulatory landscapes. Cultivated X reported in February 2025 that Dutch precision fermentation company Vivici secured a manufacturing partnership with US-based Liberation Labs for its beta-lactoglobulin protein ingredient, targeting commercial-scale output by 2026. Pooling resources and mitigating risks fosters faster market penetration.

A pivotal trend in the global cell-based milk market is the relentless pursuit of enhanced sensory and nutritional mimicry, aiming for products indistinguishable from conventional dairy. Achieving parity in taste, texture, and nutritional profile is essential for broad consumer adoption. According to the International Dairy Foods Association, rising dairy consumption in the United States is driven by consumers prioritizing protein and nutrition, establishing a high benchmark for cell-based alternatives. Significant investments are replicating milk's complex molecular composition. DairyReporter noted in March 2025 that French biotech firm Verley launched functionalized precision fermentation dairy proteins, claiming an 11% increase in leucine over native whey protein isolate, directly addressing nutritional superiority while enhancing taste and texture. This commitment seeks to overcome prior dairy alternative shortcomings, positioning cell-based milk as a competitive, functionally equivalent option.

Segmental Insights

The human breast milk segment is emerging as the fastest-growing area within the global cell-based milk market. This rapid expansion is predominantly driven by increasing consumer demand for nutritionally superior and ethically produced infant feeding solutions that circumvent conventional animal agriculture. Cell-based human breast milk aims to replicate the intricate composition and health benefits of natural maternal milk, offering a more complete nutritional profile for infant development compared to traditional bovine-based formulas. This innovation also addresses the widespread challenge of insufficient natural milk supply, providing a vital alternative for caregivers unable to breastfeed. Regulatory bodies, such as Australia's Food Regulation Standing Committee, are actively developing frameworks to ensure these novel products meet stringent safety and nutritional criteria for infant consumption.

Regional Insights

North America stands as the leading region in the Global Cell Based Milk Market due to a robust ecosystem of innovation and significant investment. The region benefits from substantial private capital allocated to cellular agriculture companies, exemplified by investment platforms like CULT Food Science that support pioneering cell-based dairy startups. Crucially, government and academic backing, such as the United States Department of Agriculture's funding for the National Institute for Cellular Agriculture at Tufts University, fosters advanced research and development in cultivated proteins. This combination of private funding, technological leadership, and institutional support from bodies like the U. S. Food and Drug Administration and the USDA, creates a fertile ground for the commercialization and expansion of cell-based milk products.

Recent Developments

  • In August 2025, Opalia, a Montreal-based company, entered into a commercial partnership with Hoogwegt, a prominent dairy ingredient provider, to advance the commercialization of cell-based dairy products. This collaboration aimed to scale up Opalia’s proof of concept for cell-cultured milk and assess its performance in various dairy applications, including cheese and ice cream. The companies planned to conduct extensive research and development over the next two years, with the objective of securing regulatory approvals by 2027 and bringing sustainable cell-based dairy to a broader market.

  • In February 2025, Brown Foods, a startup based in Boston, announced a significant breakthrough with its development of UnReal Milk, a whole milk product created using mammalian cell culture technology. This cultivated milk was reported to be molecularly identical to cow’s milk, containing the same dairy proteins, fats, and carbohydrates. The company confirmed that independent testing was underway, with initial consumer tastings for UnReal Milk version 2.0 anticipated in late 2025, followed by a market pilot projected for late 2026.

  • In February 2024, Unilever, through its Breyers brand, launched a new lactose-free chocolate frozen dairy dessert in collaboration with Perfect Day. This product incorporated whey protein developed by Perfect Day using precision fermentation, providing an animal-free alternative to traditional dairy. The frozen dessert became available nationwide, marking Unilever's entry into the animal-free dairy sector and demonstrating a commitment to offering more sustainable and ethical product options to consumers.

  • In January 2024, Imagindairy, an Israeli food technology company, achieved a crucial regulatory milestone by receiving approval from the US Food and Drug Administration (FDA) for its animal-free proteins. This clearance validated the safety of Imagindairy’s precision fermentation technology, which produces milk proteins identical to those found in cow's milk without animal involvement. This regulatory success was a pivotal step, enabling Imagindairy to pursue collaborations with food manufacturers for the commercial introduction of various animal-free dairy products, such as cheese, yogurt, and ice cream, into the US market.

Key Market Players

  • Wilk Technologies Ltd.
  • TurtleTree Labs Pte. Ltd.
  • BIOMILQ, Inc.
  • Calidad Pascual S.A.U.
  • Nestlé S.A.
  • BetterMilk Inc.
  • Opalia Co.
  • Perfect Day, Inc.
  • Formo Foods (Legendairy Foods)
  • Better Dairy

By Type

By Cell Source

By Form

By Region

  • Raw Milk
  • Human Breast Milk
  • Cows
  • Goat
  • Sheep
  • Camels
  • Mammalian Cells
  • Others
  • Powder
  • Liquid
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa
  • Report Scope:

    In this report, the Global Cell Based Milk Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

    • Cell Based Milk Market, By Type:

    o   Raw Milk

    o   Human Breast Milk

    • Cell Based Milk Market, By Cell Source:

    o   Cows

    o   Goat

    o   Sheep

    o   Camels

    o   Mammalian Cells

    o   Others

    • Cell Based Milk Market, By Form:

    o   Powder

    o   Liquid

    • Cell Based Milk Market, By Region:

    o   North America

    §  United States

    §  Canada

    §  Mexico

    o   Europe

    §  France

    §  United Kingdom

    §  Italy

    §  Germany

    §  Spain

    o   Asia Pacific

    §  China

    §  India

    §  Japan

    §  Australia

    §  South Korea

    o   South America

    §  Brazil

    §  Argentina

    §  Colombia

    o   Middle East & Africa

    §  South Africa

    §  Saudi Arabia

    §  UAE

    Competitive Landscape

    Company Profiles: Detailed analysis of the major companies presents in the Global Cell Based Milk Market.

    Available Customizations:

    Global Cell Based Milk Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

    Company Information

    • Detailed analysis and profiling of additional market players (up to five).

    Global Cell Based Milk Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

    Table of content

    Table of content

    1.    Product Overview

    1.1.  Market Definition

    1.2.  Scope of the Market

    1.2.1.  Markets Covered

    1.2.2.  Years Considered for Study

    1.2.3.  Key Market Segmentations

    2.    Research Methodology

    2.1.  Objective of the Study

    2.2.  Baseline Methodology

    2.3.  Key Industry Partners

    2.4.  Major Association and Secondary Sources

    2.5.  Forecasting Methodology

    2.6.  Data Triangulation & Validation

    2.7.  Assumptions and Limitations

    3.    Executive Summary

    3.1.  Overview of the Market

    3.2.  Overview of Key Market Segmentations

    3.3.  Overview of Key Market Players

    3.4.  Overview of Key Regions/Countries

    3.5.  Overview of Market Drivers, Challenges, Trends

    4.    Voice of Customer

    5.    Global Cell Based Milk Market Outlook

    5.1.  Market Size & Forecast

    5.1.1.  By Value

    5.2.  Market Share & Forecast

    5.2.1.  By Type (Raw Milk, Human Breast Milk)

    5.2.2.  By Cell Source (Cows, Goat, Sheep, Camels, Mammalian Cells, Others)

    5.2.3.  By Form (Powder, Liquid)

    5.2.4.  By Region

    5.2.5.  By Company (2024)

    5.3.  Market Map

    6.    North America Cell Based Milk Market Outlook

    6.1.  Market Size & Forecast

    6.1.1.  By Value

    6.2.  Market Share & Forecast

    6.2.1.  By Type

    6.2.2.  By Cell Source

    6.2.3.  By Form

    6.2.4.  By Country

    6.3.    North America: Country Analysis

    6.3.1.    United States Cell Based Milk Market Outlook

    6.3.1.1.  Market Size & Forecast

    6.3.1.1.1.  By Value

    6.3.1.2.  Market Share & Forecast

    6.3.1.2.1.  By Type

    6.3.1.2.2.  By Cell Source

    6.3.1.2.3.  By Form

    6.3.2.    Canada Cell Based Milk Market Outlook

    6.3.2.1.  Market Size & Forecast

    6.3.2.1.1.  By Value

    6.3.2.2.  Market Share & Forecast

    6.3.2.2.1.  By Type

    6.3.2.2.2.  By Cell Source

    6.3.2.2.3.  By Form

    6.3.3.    Mexico Cell Based Milk Market Outlook

    6.3.3.1.  Market Size & Forecast

    6.3.3.1.1.  By Value

    6.3.3.2.  Market Share & Forecast

    6.3.3.2.1.  By Type

    6.3.3.2.2.  By Cell Source

    6.3.3.2.3.  By Form

    7.    Europe Cell Based Milk Market Outlook

    7.1.  Market Size & Forecast

    7.1.1.  By Value

    7.2.  Market Share & Forecast

    7.2.1.  By Type

    7.2.2.  By Cell Source

    7.2.3.  By Form

    7.2.4.  By Country

    7.3.    Europe: Country Analysis

    7.3.1.    Germany Cell Based Milk Market Outlook

    7.3.1.1.  Market Size & Forecast

    7.3.1.1.1.  By Value

    7.3.1.2.  Market Share & Forecast

    7.3.1.2.1.  By Type

    7.3.1.2.2.  By Cell Source

    7.3.1.2.3.  By Form

    7.3.2.    France Cell Based Milk Market Outlook

    7.3.2.1.  Market Size & Forecast

    7.3.2.1.1.  By Value

    7.3.2.2.  Market Share & Forecast

    7.3.2.2.1.  By Type

    7.3.2.2.2.  By Cell Source

    7.3.2.2.3.  By Form

    7.3.3.    United Kingdom Cell Based Milk Market Outlook

    7.3.3.1.  Market Size & Forecast

    7.3.3.1.1.  By Value

    7.3.3.2.  Market Share & Forecast

    7.3.3.2.1.  By Type

    7.3.3.2.2.  By Cell Source

    7.3.3.2.3.  By Form

    7.3.4.    Italy Cell Based Milk Market Outlook

    7.3.4.1.  Market Size & Forecast

    7.3.4.1.1.  By Value

    7.3.4.2.  Market Share & Forecast

    7.3.4.2.1.  By Type

    7.3.4.2.2.  By Cell Source

    7.3.4.2.3.  By Form

    7.3.5.    Spain Cell Based Milk Market Outlook

    7.3.5.1.  Market Size & Forecast

    7.3.5.1.1.  By Value

    7.3.5.2.  Market Share & Forecast

    7.3.5.2.1.  By Type

    7.3.5.2.2.  By Cell Source

    7.3.5.2.3.  By Form

    8.    Asia Pacific Cell Based Milk Market Outlook

    8.1.  Market Size & Forecast

    8.1.1.  By Value

    8.2.  Market Share & Forecast

    8.2.1.  By Type

    8.2.2.  By Cell Source

    8.2.3.  By Form

    8.2.4.  By Country

    8.3.    Asia Pacific: Country Analysis

    8.3.1.    China Cell Based Milk Market Outlook

    8.3.1.1.  Market Size & Forecast

    8.3.1.1.1.  By Value

    8.3.1.2.  Market Share & Forecast

    8.3.1.2.1.  By Type

    8.3.1.2.2.  By Cell Source

    8.3.1.2.3.  By Form

    8.3.2.    India Cell Based Milk Market Outlook

    8.3.2.1.  Market Size & Forecast

    8.3.2.1.1.  By Value

    8.3.2.2.  Market Share & Forecast

    8.3.2.2.1.  By Type

    8.3.2.2.2.  By Cell Source

    8.3.2.2.3.  By Form

    8.3.3.    Japan Cell Based Milk Market Outlook

    8.3.3.1.  Market Size & Forecast

    8.3.3.1.1.  By Value

    8.3.3.2.  Market Share & Forecast

    8.3.3.2.1.  By Type

    8.3.3.2.2.  By Cell Source

    8.3.3.2.3.  By Form

    8.3.4.    South Korea Cell Based Milk Market Outlook

    8.3.4.1.  Market Size & Forecast

    8.3.4.1.1.  By Value

    8.3.4.2.  Market Share & Forecast

    8.3.4.2.1.  By Type

    8.3.4.2.2.  By Cell Source

    8.3.4.2.3.  By Form

    8.3.5.    Australia Cell Based Milk Market Outlook

    8.3.5.1.  Market Size & Forecast

    8.3.5.1.1.  By Value

    8.3.5.2.  Market Share & Forecast

    8.3.5.2.1.  By Type

    8.3.5.2.2.  By Cell Source

    8.3.5.2.3.  By Form

    9.    Middle East & Africa Cell Based Milk Market Outlook

    9.1.  Market Size & Forecast

    9.1.1.  By Value

    9.2.  Market Share & Forecast

    9.2.1.  By Type

    9.2.2.  By Cell Source

    9.2.3.  By Form

    9.2.4.  By Country

    9.3.    Middle East & Africa: Country Analysis

    9.3.1.    Saudi Arabia Cell Based Milk Market Outlook

    9.3.1.1.  Market Size & Forecast

    9.3.1.1.1.  By Value

    9.3.1.2.  Market Share & Forecast

    9.3.1.2.1.  By Type

    9.3.1.2.2.  By Cell Source

    9.3.1.2.3.  By Form

    9.3.2.    UAE Cell Based Milk Market Outlook

    9.3.2.1.  Market Size & Forecast

    9.3.2.1.1.  By Value

    9.3.2.2.  Market Share & Forecast

    9.3.2.2.1.  By Type

    9.3.2.2.2.  By Cell Source

    9.3.2.2.3.  By Form

    9.3.3.    South Africa Cell Based Milk Market Outlook

    9.3.3.1.  Market Size & Forecast

    9.3.3.1.1.  By Value

    9.3.3.2.  Market Share & Forecast

    9.3.3.2.1.  By Type

    9.3.3.2.2.  By Cell Source

    9.3.3.2.3.  By Form

    10.    South America Cell Based Milk Market Outlook

    10.1.  Market Size & Forecast

    10.1.1.  By Value

    10.2.  Market Share & Forecast

    10.2.1.  By Type

    10.2.2.  By Cell Source

    10.2.3.  By Form

    10.2.4.  By Country

    10.3.    South America: Country Analysis

    10.3.1.    Brazil Cell Based Milk Market Outlook

    10.3.1.1.  Market Size & Forecast

    10.3.1.1.1.  By Value

    10.3.1.2.  Market Share & Forecast

    10.3.1.2.1.  By Type

    10.3.1.2.2.  By Cell Source

    10.3.1.2.3.  By Form

    10.3.2.    Colombia Cell Based Milk Market Outlook

    10.3.2.1.  Market Size & Forecast

    10.3.2.1.1.  By Value

    10.3.2.2.  Market Share & Forecast

    10.3.2.2.1.  By Type

    10.3.2.2.2.  By Cell Source

    10.3.2.2.3.  By Form

    10.3.3.    Argentina Cell Based Milk Market Outlook

    10.3.3.1.  Market Size & Forecast

    10.3.3.1.1.  By Value

    10.3.3.2.  Market Share & Forecast

    10.3.3.2.1.  By Type

    10.3.3.2.2.  By Cell Source

    10.3.3.2.3.  By Form

    11.    Market Dynamics

    11.1.  Drivers

    11.2.  Challenges

    12.    Market Trends & Developments

    12.1.  Merger & Acquisition (If Any)

    12.2.  Product Launches (If Any)

    12.3.  Recent Developments

    13.    Global Cell Based Milk Market: SWOT Analysis

    14.    Porter's Five Forces Analysis

    14.1.  Competition in the Industry

    14.2.  Potential of New Entrants

    14.3.  Power of Suppliers

    14.4.  Power of Customers

    14.5.  Threat of Substitute Products

    15.    Competitive Landscape

    15.1.  Wilk Technologies Ltd.

    15.1.1.  Business Overview

    15.1.2.  Products & Services

    15.1.3.  Recent Developments

    15.1.4.  Key Personnel

    15.1.5.  SWOT Analysis

    15.2.  TurtleTree Labs Pte. Ltd.

    15.3.  BIOMILQ, Inc.

    15.4.  Calidad Pascual S.A.U.

    15.5.  Nestlé S.A.

    15.6.  BetterMilk Inc.

    15.7.  Opalia Co.

    15.8.  Perfect Day, Inc.

    15.9.  Formo Foods (Legendairy Foods)

    15.10.  Better Dairy

    16.    Strategic Recommendations

    17.    About Us & Disclaimer

    Figures and Tables

    Frequently asked questions

    Frequently asked questions

    The market size of the Global Cell Based Milk Market was estimated to be USD 490.08 Million in 2024.

    North America is the dominating region in the Global Cell Based Milk Market.

    Human Breast Milk segment is the fastest growing segment in the Global Cell Based Milk Market.

    The Global Cell Based Milk Market is expected to grow at 8.80% between 2025 to 2030.

    Related Reports

    We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.